Agents and Actions

, Volume 20, Issue 3–4, pp 226–228 | Cite as

Isolation and sensitivity of human mesenteric mast cells to immunological and nonimmunological histamine releasers

  • E. Brzezińska-Błaszczyk
  • M. Czuwaj
Mast Cells and Basophils


Since recent studies have emphasized that mast cells from different tissues within a given species may exhibit marked differences in their functional properties, we have now examined the effect of some immunological and non-immunological histamine releasers on human mesenteric mast cells. The mesentery derived from the patients subjected to gall-bladder surgery was dispersed by collagenase (concentration of enzyme — 1 mg/ml, time of incubation — 90 min, 37°C). The mesenteric cell suspension contained about 2% mast cells as identified by staining with toluidine blue. We observed that the mesenteric mast cells released histamine when challenged with anti-human IgE, but marked individual variations were observed. These cells had a low sensitivity to challenge with Concanavalin A and compound 48/80 (histamine release about 6%), but responded to ionophore A23187 and polymyxin B (histamine release up to 24% and 22% respectively).


Cell Suspension Mast Cell Histamine Functional Property Collagenase 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. [1]
    K. E. Barrett and D. D. Metcalfe,Mast cell heterogeneity: evidence and implications. J. Clin. Immunol.4, 253–261 (1984).PubMedGoogle Scholar
  2. [2]
    F. L. Pearce,Mast cell heterogeneity. Trends pharmacol. Sci.4, 165–167 (1983).Google Scholar
  3. [3]
    F. L. Pearce and M. Ennis,Isolation and some properties of mast cells from the mesentery of the rat and guinea pig. Agents and Actions10, 124–131 (1980).PubMedGoogle Scholar
  4. [4]
    P. A. Shore, A. Burkhalter and V. H. Cohn,A method for the fluorometric assay of histamine in tissues. J. Pharmacol. exp. Ther.127, 182–186 (1959).PubMedGoogle Scholar
  5. [5]
    M. Ennis,Histamine release from human pulmonary mast cells. Agents and Actions12, 60–63 (1982).PubMedGoogle Scholar
  6. [6]
    K. B. P. Leung, K. C. Flint, J. Brostoff, B. N. Hudspith, N. McI. Johnson and F. L. Pearce,Some properties of mast cells obtained by human bronchoalveolar lavage. Agents and Actions18, 110–112 (1986).PubMedGoogle Scholar
  7. [7]
    W. Schmutzler, K. Delmich, D. Eichelberg, S. Gluck, T. Greven, H. Jurgensen, K. P. Riesener, G. Risse and P. Pult,The human adenoidal mast cells. Susceptibility to different secretagogues and secretion inhibitors. Int. Archs Allergy appl. Immunol.77 177–178 (1985).Google Scholar
  8. [8]
    M. Ennis and F. L. Pearce,Differential reactivity of isolated mast cells from the rat and guinea-pig. Eur. J. Pharmacol.66, 339–345 (1980).PubMedGoogle Scholar
  9. [9]
    P. T. Peachell and F. L. Pearce,Some studies on the release of histamine from mast cells treated with polymyxin. Agents and Actions14, 379–385 (1984).PubMedGoogle Scholar

Copyright information

© Birkhäuser Verlag 1987

Authors and Affiliations

  • E. Brzezińska-Błaszczyk
    • 1
  • M. Czuwaj
    • 1
  1. 1.Department of Biogenic AminesPolish Academy of SciencesŁódźPoland

Personalised recommendations